长期COVID的高压氧气治疗的有效性和安全性:系统审查和元分析的协议
Yuxin Li1,2, Jingnan Lin1,2, Jiazhu Gao1,2
1Guangzhou University of Chinese Medicine, Guangzhou, China.
本系统性审查评估了长期COVID的高压氧疗法 (HBOT). 它的目的是澄清HBOT.
科学领域:
- 医学研究 医学研究
- 肺部病理学 肺部病理学
- 神经学 神经学
背景情况:
- 对于长期COVID患者,治疗选择有限.
- 高压氧疗法 (HBOT) 显示了长期COVID的潜在益处.
- 在长期COVID中,HBOT的疗效和安全性需要进一步调查.
研究的目的:
- 系统地审查和评估高压氧疗法 (HBOT) 的可行性.
- 评估HBOT作为长期COVID的主要或补充治疗方法.
主要方法:
- 在多个数据库 (Web of Science,PubMed,Embase等) 中进行全面的系统搜索. 在2023年12月9日之前.
- 两个审稿人对所有已识别的文章进行独立审查.
- 使用Cochrane偏差风险评估工具进行偏差风险评估,并通过漏斗图谱检查进行异质性评估.
- 如果确定了足够的研究,将进行元分析.
主要成果:
- 结果正在等待系统审查和元分析.
结论:
- 这些发现将确定HBOT在管理长期COVID的潜在作用.
- 这次审查将为临床实践提供有关长期COVID的HBOT的信息.
更多相关视频
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
14:28Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
Published on: May 10, 2024
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
